Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: August presentation from PTSC home page
Reply New Message
Prev Message Back To Forum Threaded View Next Message

    1. I think these are RG's concerns.(from PTSC web site) Not that he is concerned about future MMP fees but more the situation that PTSC finds itself in the present. He is to date the only of our recent CEO's to do anything about the below.



        1. Licensing agreements preclude disclosure of contract details
        2. Would have negative impact on future MMP license negotiations



        1. PTSC has been subject to stock price jitters on:
        2. Heavy retail (near 90%), limited institutional investor base

        3. Lack of visibility to new licensees, inability to forecast future revenues


        4. USPTO patent re-examinations, Patent Reform Act legislation


        5. Becoming an operating company can mitigate these concerns




        1 Recommendations
        Reply New Message
        Prev Message Back To Forum Threaded View Next Message
        Share
        Share
        New Message
        Please login to post a reply